Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
928.85
-7.50 (-0.80%) Zydus Lifesciences - Quaterly Results
Date: 10-08-2022
Net sales declined -6.71% to Rs. 19809.00 million from Rs. 21234.00 millions.Net profit declined -17.10% to Rs. 3315.00 millions from Rs. 3999.00 millions.Operating Profit reported a sharp decline to 5960.00 millions from 6473.00 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202206 | 202106 | % Var | 202206 | 202106 | % Var | 202203 | 202103 | % Var | |
| Sales | 19809.00 | 21234.00 | -6.71 | 19809.00 | 21234.00 | -6.71 | 79819.00 | 77800.00 | 2.60 |
| Other Income | 517.00 | 297.00 | 74.07 | 517.00 | 297.00 | 74.07 | 1787.00 | 893.00 | 100.11 |
| PBIDT | 5960.00 | 6473.00 | -7.93 | 5960.00 | 6473.00 | -7.93 | 20968.00 | 23980.00 | -12.56 |
| Interest | 406.00 | 442.00 | -8.14 | 406.00 | 442.00 | -8.14 | 1349.00 | 709.00 | 90.27 |
| PBDT | 5554.00 | 6031.00 | -7.91 | 5554.00 | 6031.00 | -7.91 | 16426.00 | 21396.00 | -23.23 |
| Depreciation | 1231.00 | 1167.00 | 5.48 | 1231.00 | 1167.00 | 5.48 | 4787.00 | 4511.00 | 6.12 |
| PBT | 4323.00 | 4864.00 | -11.12 | 4323.00 | 4864.00 | -11.12 | 11639.00 | 16885.00 | -31.07 |
| TAX | 1008.00 | 865.00 | 16.53 | 1008.00 | 865.00 | 16.53 | 3060.00 | 2123.00 | 44.14 |
| Deferred Tax | -6.00 | 15.00 | -140.00 | -6.00 | 15.00 | -140.00 | 458.00 | -910.00 | -150.33 |
| PAT | 3315.00 | 3999.00 | -17.10 | 3315.00 | 3999.00 | -17.10 | 8579.00 | 14762.00 | -41.88 |
| Equity | 1024.00 | 1024.00 | 0.00 | 1024.00 | 1024.00 | 0.00 | 1024.00 | 1024.00 | 0.00 |
| PBIDTM(%) | 30.09 | 30.48 | -1.30 | 30.09 | 30.48 | -1.30 | 26.27 | 30.82 | -14.77 |